Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | GBA1 | P04062 | 3/20 | 0.44 |
| ▸ | UGCG | Q16739 | 2/20 | 0.44 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | TEAD3 | Q99594 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31399430 | 1.00 | L3MBTL1 (0.50) | L3MBTL1TDP1GBA1UGCGGBA2 | |
| SCHEMBL31399566 | 1.00 | L3MBTL1 (0.50) | L3MBTL1TDP1GBA1UGCGGBA2 | |
| SCHEMBL31399582 | 1.00 | L3MBTL1 (0.50) | L3MBTL1TDP1GBA1UGCGGBA2 | |
| SCHEMBL31399445 | 1.00 | L3MBTL1 (0.50) | L3MBTL1TDP1GBA1UGCGGBA2 | |
| SCHEMBL23743657 | 0.85 | L3MBTL1 (0.46) | L3MBTL1TDP1TSHREPHX2TEAD3 | |
| SCHEMBL21677902 | 0.85 | L3MBTL1 (0.46) | L3MBTL1TDP1TSHREPHX2TEAD3 | |
| SCHEMBL9712613 | 0.84 | L3MBTL1 (0.47) | L3MBTL1TDP1GBA1UGCGGBA2 | |
| SCHEMBL9712481 | 0.82 | TSHR (0.45) | L3MBTL1TDP1GBA1UGCGGBA2 | |
| SCHEMBL23743658 | 0.82 | L3MBTL1 (0.46) | L3MBTL1TDP1EPHX2TEAD3ALDH1A1 | |
| SCHEMBL24703878 | 0.82 | L3MBTL1 (0.46) | L3MBTL1TDP1EPHX2TEAD3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739652-A1 | LIPIDS AND COMPOSITIONS THEREOF | Kernal Biologics, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20260116845-A1 | LIPIDS AND COMPOSITIONS THEREOF | KERNAL BIOLOGICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| WO-2025010290-A1 | LIPIDS AND COMPOSITIONS THEREOF | KERNAL BIOLOGICS, INC. (US) | 2025-01-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116845-A1 | LIPIDS AND COMPOSITIONS THEREOF | LIPC, LIPA, NPC1L1 | L3MBTL1 295/4885TDP1 1579/4885GBA1 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.